Skip to main content

APAC is projected to be the fastest-growing High Performance Bioinformatics Market

According to the new market research report “Bioinformatics Platforms Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) – Global Forecast to 2023″, , published by MarketsandMarkets™,The global bioinformatics market is expected to account for USD 7,063.7 billion in 2018. It is expected to reach USD 13,901.5 billion by 2023, at a CAGR of 14.5% during the forecast period.

Browse in-depth TOC on “Bioinformatics Market
189 – Tables
27 – Figures
195 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39


Growth of the bioinformatics Platforms Market is driven by the growing demand for nucleic acid and protein sequencing, increasing government initiatives and funding, and increasing use of bioinformatics in drug discovery and biomarker development processes. With the introduction of upcoming technologies such as nanopore sequencing (third generation sequencing technique) and cloud computing, the market is expected to offer significant opportunities for manufacturers of bioinformatics solutions

By Application, the metabolomics segment is expected to grow at the highest CAGR during the forecast period :

Factors such as the availability of research funding and government support are fueling market growth. However, metabolomes cannot be easily identified or figured from reconstructed biochemical pathways due to enzymatic diversity, substrate ambiguity, and difference in regulatory mechanisms. Hence, the annotation of unknown metabolic signals is the main hindrance to growth of the metabolomics segment

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=39

The APAC market is expected to grow at the highest CAGR during the forecast period

The market in the Asia Pacific region is expected to offer significant opportunities for players to offset revenue losses incurred in mature markets. Emerging countries in this region are witnessing growth in their GDPs and a significant rise in disposable income levels. This has led to increased healthcare spending by a larger population base, healthcare infrastructure modernization, and rising penetration of cutting-edge research and clinical laboratory technologies, including bioinformatics, in Asia Pacific countries.

Prominent players in the Bioinformatics Platforms Market are Alere (US), Thermo Fisher (US), Drägerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US). While, LabCorp (US), Quest Diagnostics (US), Omega Laboratories (US), Psychemedics (US), CRL (US), SureHire (Canada), and CannAmm (Canada) are some of key players offering Bioinformatics Market.

Comments

Popular posts from this blog

Potential Impact Of COVID-19 On Walking Assist Devices Market

The global market is expected to witness growth in the coming years, owing to factors such as the increase in the number of initiatives undertaken by governments of various countries to ensure availability of walking assist devices to a huge consumer base, rise in aging population, and increasing incidences of Debilitating Neurological Diseases & Injuries.The global walking assist devices market is expected to reach $6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020.Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW) – Global Forecast to 2020
Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=98811670Global Walking Assist Devices Market is Segmented on:1. Product Type
2. GeographyProduct TypeBased on product, the global market is classified into gaits belts and lift vests, canes, crutches, walkers, wheelchairs, an…

Glycomics Market COVID – 19 Updated Analysis By Top Key Players – Merck KGaA , Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific

The growth of this market is majorly driven by the increasing research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth in the proteomics market. On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment.The global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (Mass Spectrometry, Chromatography), Carbohydrates, Reagents & Chemicals), Application (Disease Diagnostics), End-User (Academic) -Global Forecasts to 2025Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
The Global Glycomics / Glycobiology Market is Segmented on:
1. Product
2. Instruments
3. Application
4. End UserThe demand for glycomics products for drug discovery & development is estimate…